Anlotinib for Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Study.
Journal of clinical oncology（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined